Skip to content

Wallgraft Tracheobronchial Endoprothesis with Unistep Plus Delivery System

by Boston Scientific Scimed, Inc.

510(k) K021901

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 10 Oct 2026. What this means

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK021901 Date9 Jul 2002ClearedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-2833-2011 FDA Unclassified (pre-2012) initiated 25 May 2011

    Boston Scientific is initiating an important field correction related to WALLSTENT", WALLSTENT" RP, and WALLGRAFT Tracheobronchial Endoprosthesis products. This letter is intended to clarify and re-emphasize that U.S. WALLSTENT", WALLSTENT" RP, and WALLGRAFT Tracheobronchial Endoprosthesis stents are NOT currently cleared by the FDA for use in benign tracheobronchial strictures.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JCT
Device Class
Class II
Regulation
21 CFR Part 878.3720
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Other devices from Boston Scientific Scimed, Inc.

See all devices from Boston Scientific Scimed, Inc. →